CN112263654A - 用于治疗弱视的膏药及其制备方法 - Google Patents
用于治疗弱视的膏药及其制备方法 Download PDFInfo
- Publication number
- CN112263654A CN112263654A CN202011423223.0A CN202011423223A CN112263654A CN 112263654 A CN112263654 A CN 112263654A CN 202011423223 A CN202011423223 A CN 202011423223A CN 112263654 A CN112263654 A CN 112263654A
- Authority
- CN
- China
- Prior art keywords
- plaster
- raw materials
- amblyopia
- fruit
- medicine package
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000009487 Amblyopia Diseases 0.000 title claims abstract description 43
- 239000011505 plaster Substances 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title abstract description 10
- 239000003814 drug Substances 0.000 claims abstract description 80
- 239000002994 raw material Substances 0.000 claims abstract description 37
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 35
- 241000222336 Ganoderma Species 0.000 claims abstract description 13
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 12
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims abstract description 12
- 240000008365 Celosia argentea Species 0.000 claims abstract description 11
- 235000000722 Celosia argentea Nutrition 0.000 claims abstract description 11
- 240000007371 Cuscuta campestris Species 0.000 claims abstract description 11
- 241000906579 Actaea cimicifuga Species 0.000 claims abstract description 9
- 241000572565 Alpinia oxyphylla Species 0.000 claims abstract description 9
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 9
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 9
- 241000830535 Ligustrum lucidum Species 0.000 claims abstract description 9
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 9
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 9
- 240000005373 Panax quinquefolius Species 0.000 claims abstract description 9
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 9
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 9
- 241000405414 Rehmannia Species 0.000 claims abstract description 9
- 240000001341 Reynoutria japonica Species 0.000 claims abstract description 9
- 235000018167 Reynoutria japonica Nutrition 0.000 claims abstract description 9
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 9
- 244000185386 Thladiantha grosvenorii Species 0.000 claims abstract description 9
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 claims abstract description 9
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 9
- 229940107666 astragalus root Drugs 0.000 claims abstract description 9
- 235000008422 Schisandra chinensis Nutrition 0.000 claims abstract description 3
- 239000007788 liquid Substances 0.000 claims description 24
- 239000000463 material Substances 0.000 claims description 20
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 12
- 239000011707 mineral Substances 0.000 claims description 12
- 235000011837 pasties Nutrition 0.000 claims description 12
- 238000002791 soaking Methods 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 244000124209 Crocus sativus Species 0.000 claims description 10
- 235000015655 Crocus sativus Nutrition 0.000 claims description 10
- 235000013974 saffron Nutrition 0.000 claims description 9
- 239000004248 saffron Substances 0.000 claims description 9
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 8
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 8
- 235000017443 Hedysarum boreale Nutrition 0.000 claims description 8
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims description 8
- 240000002624 Mespilus germanica Species 0.000 claims description 8
- 240000000249 Morus alba Species 0.000 claims description 8
- 235000008708 Morus alba Nutrition 0.000 claims description 8
- 240000003705 Senecio vulgaris Species 0.000 claims description 8
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 7
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 6
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 6
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims description 6
- 241001113925 Buddleja Species 0.000 claims description 6
- 241000723346 Cinnamomum camphora Species 0.000 claims description 6
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 6
- 229940116229 borneol Drugs 0.000 claims description 6
- 229930008380 camphor Natural products 0.000 claims description 6
- 229960000846 camphor Drugs 0.000 claims description 6
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 6
- 235000012907 honey Nutrition 0.000 claims description 6
- 238000000465 moulding Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 244000131316 Panax pseudoginseng Species 0.000 claims description 5
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims description 5
- 241000336315 Cistanche salsa Species 0.000 claims description 3
- 241000180649 Panax notoginseng Species 0.000 claims description 3
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 3
- 241000123846 Buddleja officinalis Species 0.000 claims description 2
- 241000336291 Cistanche deserticola Species 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 244000182216 Mimusops elengi Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 19
- 230000004438 eyesight Effects 0.000 description 19
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 210000004185 liver Anatomy 0.000 description 12
- 230000017531 blood circulation Effects 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 7
- 230000003750 conditioning effect Effects 0.000 description 5
- 240000008397 Ganoderma lucidum Species 0.000 description 4
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 4
- 241000475481 Nebula Species 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 208000001491 myopia Diseases 0.000 description 4
- 230000004379 myopia Effects 0.000 description 4
- 241000005787 Cistanche Species 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000004377 improving vision Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- RDMQPKIDHAFXKA-JNORPAGFSA-N Ganoderic Acid Am1 Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC(=O)C1=C2C(=O)C[C@]2(C)[C@@H]([C@@H](CC(=O)CC(C)C(O)=O)C)CC(=O)[C@]21C RDMQPKIDHAFXKA-JNORPAGFSA-N 0.000 description 1
- 229930182735 Ganoderic acid Natural products 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 210000005091 airway smooth muscle Anatomy 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 210000000695 crystalline len Anatomy 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000004392 development of vision Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- SZGZILRQIYNODJ-UHFFFAOYSA-L disodium;7,12-dihydroquinoxalino[3,2-b]phenazine-2,9-disulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC=C2N=C(C=C3C(NC4=CC=C(C=C4N3)S(=O)(=O)[O-])=C3)C3=NC2=C1 SZGZILRQIYNODJ-UHFFFAOYSA-L 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000001050 pharmacotherapy Methods 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000008203 tachypnea Diseases 0.000 description 1
- 206010043089 tachypnoea Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Marine Sciences & Fisheries (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于治疗弱视的膏药及其制备方法,属于中药技术领域。解决了现有技术治疗弱视成本高、效果差的问题,所述的用于治疗弱视的膏药,包括药包一、药包二以及药包三,其中药包一包括以下原料:青葙子8‑12克,枸杞子8‑12克,黄芪3‑6克,五味子8‑12克,升麻12‑18克,茯神12‑18克,益智仁12‑18克,决明子18‑22克,女贞子3‑8克,熟地3‑8克,罗汉果1个,何首乌6‑11克,灵芝10‑12克,西洋参45‑55克,菟丝子8‑12克,菊花8‑12克。本发明可用于治疗弱视。
Description
技术领域
本发明涉及一种用于治疗弱视的膏药及其制备方法,属于中药技术领域。
背景技术
随着电子产品的快速发展,儿童能接触到的电子产品越来越多,使用时间越来越长,由于不良的用眼习惯和用眼环境导致眼睛问题越来越低龄化,弱视已经成为儿童成长过程中不容忽视的健康问题。弱视是指单眼或双眼最佳矫正视力低于相应年龄的视力,但是眼部检查无器质性病变,这是视觉发育期由于异常的视觉经验引起的。
近视和弱视可以同在,但是这是两种截然不同的疾病,近视多由眼睫状肌过度紧张,晶状体曲度变大,或其他原因造成眼轴变长,致使患儿远视力下降,但是能看清近处的事物,且配带矫正眼镜后视力可以恢复正常。弱视涉及视功能发育异常,患儿即使佩戴眼镜视力也无法矫正至正常,因此弱视更应该引起家长的注意。现有的矫正弱视的方法包括消除病因、光学矫正、遮盖治疗以及光学药物疗法等,但是都存在矫正周期长、矫正效果差的问题。
发明内容
本发明的目的在于提供一种用于治疗弱视的膏药及其制备方法,具有用药安全、费用低、效果好、使用方便的优点。
所述的用于治疗弱视的膏药,包括药包一、药包二以及药包三,其中药包一包括以下原料:青葙子8-12克,枸杞子8-12克,黄芪3-6克,五味子8-12克,升麻12-18克,茯神12-18克,益智仁12-18克,决明子18-22克,女贞子3-8克,熟地3-8克,罗汉果1个,何首乌6-11克,灵芝10-12克,西洋参45-55克,菟丝子8-12克,菊花8-12克。
进一步地讲,所述的药包二包括以下原料:桑葚子45-55克,密蒙花45-55克,千里光30-40克,炙甘草8-12克,藏红花3-8克。
进一步地讲,所述的药包三包括以下原料:石决明3-8克,三七3-8克,肉苁蓉3-8克。
进一步地讲,药包一包括以下原料:青葙子10克,枸杞子10克,黄芪5克,五味子10克,升麻15克,茯神15克,益智仁15克,决明子20克,女贞子5克,熟地5克,罗汉果1个,何首乌9克,灵芝11克,西洋参50克,菟丝子10克,菊花10克。
进一步地讲,所述的药包二包括以下原料:桑葚子50克,密蒙花50克,千里光35克,炙甘草10克,藏红花5克。
进一步地讲,所述的药包三包括以下原料:石决明5克,三七5克,肉苁蓉5克。
所述的用于治疗弱视的膏药的制备方法,包括以下步骤:
(1)将药包一中的原料打碎,加入200-300克矿泉水浸泡20-40分钟,得料液一;
(2)将药包二中的原料打碎,加入200-300克矿泉水浸泡20-40分钟,得料液二;
(3)取200克蜂蜜熬制8-12分钟,加入料液一继续熬制45-60分钟后再加入料液二继续熬制成膏状药出锅;
(4)待膏状药冷却至8-15℃,将药包三打碎,加入至膏状药中并搅拌均匀;
(5)最后加入樟脑10克、冰片10克,成型即得到所述的用于治疗弱视的膏药。
药材的熬制时间是根据各个药材的耐久性决定的。
青葙子具有清肝泄火,明目退翳的功效。临床主要用于肝热目赤,目生翳膜,视物昏花,肝火眩晕等病证。本品的性味归经为,苦,微寒,主要归肝经。
藏红花在药典上记载为性味较甘平,它主要作用在于养血、活血、补血和行血等,包括活血化瘀、凉血解毒、解郁安神、美容养颜等。同时在使用中,还能够调节内分泌,特别是促进体内的血液循环,提高血液的供氧能力,对人体免疫力、抵抗力有一定的提高效果,包括改善人体的体质。
灵芝 味甘,性温,入心、脾、肾、肺四经,可以养心安神、养肺益气、理气化瘀、滋肝健脾。主治虚劳体弱、神疲乏力、心悸失眠、头目昏晕、久咳气喘、食欲不振、呼吸急促等。
随着现代医学研究的深入,灵芝的多种药理作用已被证实,具体如下:
1、具有调节免疫的作用,灵芝可以提高人体当中免疫细胞的活性和数量,因而具有增强机体免疫功能的作用,特别是在肝损伤以及抑制肝炎病毒复制方面起到了一定的作用,有保肝解毒的作用;
2、可以延缓衰老。研究显示,灵芝当中的多糖类成分能够增加超氧化物歧化酶的活性,可以帮助清除体内的氧化自由基,进而达到延缓衰老、美容护肤的作用;
3、有保护血管的作用,药理研究显示,灵芝具有扩张冠状动脉的作用,因而可以帮助增强冠脉血流量,改善血液循环,在心脑血管疾病方面起到预防作用。还可以降低血中的胆固醇、脂蛋白和甘油三酯,并且可以预防动脉粥样硬化斑块的形成;
4、祛痰止咳的作用,从灵芝中能提取灵芝酸,具有松弛气道平滑肌的作用,在呼吸系统中,可以起到祛痰止咳的良好的作用;
5、抗肿瘤的作用,具有抑制肿瘤血管新生,使肿瘤细胞生长得以抑制,抗肿瘤的作用,这是灵芝的抗肿瘤的作用;
6、镇静安神的作用,对中枢系统有较强的调节作用,所以可以起到镇静安神的功效,可以治疗神经衰弱。
菟丝子,有补肾益精,养肝明目功效。
菊花,古人把菊花称之为延寿客 味甘、苦,稍微有点寒,归肺、肝两经,主要功效与作用是疏散风热、平肝明目、清热解毒。
在近视药膏基础上加入菟丝子和菊花两味药物,有补肾益精、清热解毒、平肝明目,通过培补肾源、平肝明目来达到治疗弱视的目的。
菟丝子、菊花以及青葙子、藏红花和灵芝相伍可以达到清肝泄火,明目退翳、养血、活血、补血和行血等功效,特别是促进体内的血液循环,提高血液的供氧能力,对人体免疫力、抵抗力有一定的提高效果,包括改善人体的体质。
还可引其他诸药之性味入五脏六腑进行调节最后引诸脏之精气上达与目,从而改善视力。
与现有技术相比本发明的有益效果是:
本发明使用常见中草药,三个药包配合使用具有养血、活血、补血和行血等功效,从而达到清肝泄火,明目退翳、改善视力的目的,本发明安全可靠,绿色无污染,有效率可以达到98.5%。
具体实施方式
下面结合具体实施例对本发明做进一步说明。
实施例1
所述的用于治疗弱视的膏药,包括药包一、药包二以及药包三,其中药包一包括以下原料:青葙子10克,枸杞子10克,黄芪5克,五味子10克,升麻15克,茯神15克,益智仁15克,决明子20克,女贞子5克,熟地5克,罗汉果1个,何首乌9克,灵芝11克,西洋参50克,菟丝子8克,菊花8克。所述的药包二包括以下原料:桑葚子50克,密蒙花50克,千里光35克,炙甘草10克,藏红花5克。所述的药包三包括以下原料:石决明5克,三七5克,肉苁蓉5克。
所述的用于治疗弱视的膏药的制备方法,包括以下步骤:
(1)将药包一中的原料打碎,加入250克矿泉水浸泡30分钟,得料液一;
(2)将药包二中的原料打碎,加入250克矿泉水浸泡30分钟,得料液二;
(3)取200克蜂蜜熬制10分钟,加入料液一继续熬制50分钟后再加入料液二继续熬制成膏状药出锅;
(4)待膏状药冷却至10℃,将药包三打碎,加入至膏状药中并搅拌均匀;
(5)最后加入樟脑10克、冰片10克,成型即得到所述的用于治疗弱视的膏药。
实施例2
所述的用于治疗弱视的膏药,包括药包一、药包二以及药包三,其中药包一包括以下原料:青葙子8克,枸杞子8克,黄芪3克,五味子8克,升麻12克,茯神12克,益智仁12克,决明子18克,女贞子3克,熟地3克,罗汉果1个,何首乌6克,灵芝10克,西洋参45克,菟丝子12克,菊花12克。所述的药包二包括以下原料:桑葚子45克,密蒙花45克,千里光30克,炙甘草8克,藏红花3克。所述的药包三包括以下原料:石决明3克,三七3克,肉苁蓉3克。
所述的用于治疗弱视的膏药的制备方法,包括以下步骤:
(1)将药包一中的原料打碎,加入200克矿泉水浸泡20分钟,得料液一;
(2)将药包二中的原料打碎,加入200克矿泉水浸泡20分钟,得料液二;
(3)取200克蜂蜜熬制8分钟,加入料液一继续熬制45分钟后再加入料液二继续熬制成膏状药出锅;
(4)待膏状药冷却至8℃,将药包三打碎,加入至膏状药中并搅拌均匀;
(5)最后加入樟脑10克、冰片10克,成型即得到所述的用于治疗弱视的膏药。
实施例3
所述的用于治疗弱视的膏药,包括药包一、药包二以及药包三,其中药包一包括以下原料:青葙子12克,枸杞子12克,黄芪6克,五味子12克,升麻18克,茯神18克,益智仁18克,决明子22克,女贞子8克,熟地8克,罗汉果1个,何首乌11克,灵芝12克,西洋参55克,菟丝子10克,菊花10克。所述的药包二包括以下原料:桑葚子55克,密蒙花55克,千里光40克,炙甘草12克,藏红花8克。所述的药包三包括以下原料:石决明8克,三七8克,肉苁蓉8克。
所述的用于治疗弱视的膏药的制备方法,包括以下步骤:
(1)将药包一中的原料打碎,加入300克矿泉水浸泡40分钟,得料液一;
(2)将药包二中的原料打碎,加入300克矿泉水浸泡40分钟,得料液二;
(3)取200克蜂蜜熬制12分钟,加入料液一继续熬制60分钟后再加入料液二继续熬制成膏状药出锅;
(4)待膏状药冷却至15℃,将药包三打碎,加入至膏状药中并搅拌均匀;
(5)最后加入樟脑10克、冰片10克,成型即得到所述的用于治疗弱视的膏药。
实施例4
所述的用于治疗弱视的膏药,包括药包一、药包二以及药包三,其中药包一包括以下原料:青葙子8克,枸杞子10克,黄芪6克,五味子9克,升麻16克,茯神14克,益智仁13克,决明子21克,女贞子6克,熟地3克,罗汉果1个,何首乌7克,灵芝10克,西洋参42克,菟丝子8克,菊花10克。所述的药包二包括以下原料:桑葚子52克,密蒙花45克,千里光33克,炙甘草11克,藏红花5克。所述的药包三包括以下原料:石决明6克,三七4克,肉苁蓉7克。
所述的用于治疗弱视的膏药的制备方法,包括以下步骤:
(1)将药包一中的原料打碎,加入250克矿泉水浸泡30分钟,得料液一;
(2)将药包二中的原料打碎,加入250克矿泉水浸泡30分钟,得料液二;
(3)取200克蜂蜜熬制10分钟,加入料液一继续熬制50分钟后再加入料液二继续熬制成膏状药出锅;
(4)待膏状药冷却至10℃,将药包三打碎,加入至膏状药中并搅拌均匀;
(5)最后加入樟脑10克、冰片10克,成型即得到所述的用于治疗弱视的膏药。
测试例:
随机挑选弱视患儿150名,年龄在2-6岁之间,使用本发明产品调理20-30天,测试视力变化情况。
本发明产品的具体使用方法为:将本发明产品按照每贴0.1克,一次15贴,贴敷于人体的1印堂+2精明+2阳白+2瞳子髎+2四百+2翳明+2外关+2太阳穴共15个穴位,每天贴敷10-12小时。
测试结果:其中142名患儿视力恢复正常,4名患儿视力明显好转,4名患儿显示无效,总有效率达到97.33%。
典型病例:
单某,男,5岁,2岁时诊断出弱视,双眼视力均在0.4以下,使用本发明产品调理25天后,患儿视力恢复正常。
武某,女,3岁,弱视筛查过程中查出弱视,使用本发明产品调理20天后,患儿视力恢复正常。
王某,女,2岁,双眼运动不协调,常歪头看周围物体,经视力检查诊断为弱视,使用本发明产品调理20天后,患儿视力恢复正常。
郑某,男,7岁,3岁时诊断出弱视,经多方治疗效果较差,使用本发明产品调理30天后,患儿视力恢复正常。
Claims (7)
1.一种用于治疗弱视的膏药,其特征在于:包括药包一、药包二以及药包三,其中药包一包括以下原料:青葙子8-12克,枸杞子8-12克,黄芪3-6克,五味子8-12克,升麻12-18克,茯神12-18克,益智仁12-18克,决明子18-22克,女贞子3-8克,熟地3-8克,罗汉果1个,何首乌6-11克,灵芝10-12克,西洋参45-55克,菟丝子8-12克,菊花8-12克。
2.根据权利要求1所述的用于治疗弱视的膏药,其特征在于:所述的药包二包括以下原料:桑葚子45-55克,密蒙花45-55克,千里光30-40克,炙甘草8-12克,藏红花3-8克。
3.根据权利要求1或2所述的用于治疗弱视的膏药,其特征在于:所述的药包三包括以下原料:石决明3-8克,三七3-8克,肉苁蓉3-8克。
4.根据权利要求1所述的用于治疗弱视的膏药,其特征在于:药包一包括以下原料:青葙子10克,枸杞子10克,黄芪5克,五味子10克,升麻15克,茯神15克,益智仁15克,决明子20克,女贞子5克,熟地5克,罗汉果1个,何首乌9克,灵芝11克,西洋参50克,菟丝子10克,菊花10克。
5.根据权利要求2所述的用于治疗弱视的膏药,其特征在于:所述的药包二包括以下原料:桑葚子50克,密蒙花50克,千里光35克,炙甘草10克,藏红花5克。
6.根据权利要求3所述的用于治疗弱视的膏药,其特征在于:所述的药包三包括以下原料:石决明5克,三七5克,肉苁蓉5克。
7.一种权利要求1所述的用于治疗弱视的膏药的制备方法,其特征在于包括以下步骤:
(1)将药包一中的原料打碎,加入200-300克矿泉水浸泡20-40分钟,得料液一;
(2)将药包二中的原料打碎,加入200-300克矿泉水浸泡20-40分钟,得料液二;
(3)取200克蜂蜜熬制8-12分钟,加入料液一继续熬制45-60分钟后再加入料液二继续熬制成膏状药出锅;
(4)待膏状药冷却至8-15℃,将药包三打碎,加入至膏状药中并搅拌均匀;
(5)最后加入樟脑10克、冰片10克,成型即得到所述的用于治疗弱视的膏药。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011423223.0A CN112263654A (zh) | 2020-12-08 | 2020-12-08 | 用于治疗弱视的膏药及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011423223.0A CN112263654A (zh) | 2020-12-08 | 2020-12-08 | 用于治疗弱视的膏药及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112263654A true CN112263654A (zh) | 2021-01-26 |
Family
ID=74350293
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011423223.0A Pending CN112263654A (zh) | 2020-12-08 | 2020-12-08 | 用于治疗弱视的膏药及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112263654A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109198790A (zh) * | 2018-10-09 | 2019-01-15 | 范江俊 | 一种自体发热明目保健鞋垫及其制备方法 |
CN109602844A (zh) * | 2019-01-22 | 2019-04-12 | 贵州侗家寨医药科技有限公司 | 一种治疗近视和弱视的中药眼药膏及其制备方法 |
CN110151866A (zh) * | 2019-06-21 | 2019-08-23 | 李美霖 | 一种用于改善视力的营养补充剂及其制备方法与用途 |
-
2020
- 2020-12-08 CN CN202011423223.0A patent/CN112263654A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109198790A (zh) * | 2018-10-09 | 2019-01-15 | 范江俊 | 一种自体发热明目保健鞋垫及其制备方法 |
CN109602844A (zh) * | 2019-01-22 | 2019-04-12 | 贵州侗家寨医药科技有限公司 | 一种治疗近视和弱视的中药眼药膏及其制备方法 |
CN110151866A (zh) * | 2019-06-21 | 2019-08-23 | 李美霖 | 一种用于改善视力的营养补充剂及其制备方法与用途 |
Non-Patent Citations (2)
Title |
---|
青淑元等: "增视汤治疗小儿弱视的临床疗效观察", 《辽宁中医杂志》 * |
黄国林: "弱视灵合后像法治疗儿童弱视", 《浙江中医杂志》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105166235A (zh) | 一种气血双补降三高的保健茶及其制备方法 | |
CN103859375A (zh) | 一种有助于增强免疫力的养生保健食品配方及其制备方法 | |
CN103330021B (zh) | 一种养生茶 | |
CN104824268A (zh) | 一种中药保健茶及其制备方法 | |
CN106138500A (zh) | 一种保健药酒及其制备方法 | |
CN110151866A (zh) | 一种用于改善视力的营养补充剂及其制备方法与用途 | |
CN105861252A (zh) | 一种灵芝保健米酒 | |
CN112263654A (zh) | 用于治疗弱视的膏药及其制备方法 | |
CN112206294A (zh) | 用于治疗近视的膏药及其制备方法 | |
CN105746805A (zh) | 一种美容养颜茶 | |
CN104587076A (zh) | 一种治疗结膜炎的中药洗液 | |
CN108888720A (zh) | 一种改善睡眠的保健品口服液及制备方法 | |
CN104689107A (zh) | 一种用于治疗近视眼的中药配方及其制备方法 | |
CN109260412A (zh) | 一种治疗近视的中药组合物 | |
CN115154548B (zh) | 一种用于增强机体免疫力的中药口服液 | |
CN109170052A (zh) | 一种石斛养胃保健茶及其制备方法 | |
CN107183427A (zh) | 一种石斛汁及其制备方法 | |
CN109988695A (zh) | 美容保健酒 | |
CN108186938A (zh) | 益肾乌发口服液 | |
CN105288150A (zh) | 一种灵芝党参酒的制备方法 | |
CN107362239A (zh) | 一种桂圆药酒 | |
CN107753589B (zh) | 一种治疗糖尿病的中药组合物及其制备工艺 | |
CN105746773A (zh) | 一种防治糖尿病认知障碍的保健茶 | |
CN107227226B (zh) | 一种复方绞股蓝粉甜米酒及其制备方法 | |
CN106047617A (zh) | 一种西洋参保健米酒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210126 |